bioAffinity Technologies ... (BIAF)
NASDAQ: BIAF
· Real-Time Price · USD
0.28
-0.06 (-16.84%)
At close: May 30, 2025, 3:59 PM
0.28
-2.65%
After-hours: May 30, 2025, 05:42 PM EDT
-16.84% (1D)
| Bid | 0.25 |
| Market Cap | 7.87M |
| Revenue (ttm) | 8.81M |
| Net Income (ttm) | -9.74M |
| EPS (ttm) | -0.71 |
| PE Ratio (ttm) | -0.4 |
| Forward PE | -1.98 |
| Analyst | Buy |
| Ask | 0.29 |
| Volume | 2,537,834 |
| Avg. Volume (20D) | 12,475,591 |
| Open | 0.32 |
| Previous Close | 0.34 |
| Day's Range | 0.28 - 0.32 |
| 52-Week Range | 0.16 - 2.99 |
| Beta | 3.03 |
About BIAF
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BIAF
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BIAF stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 days ago
+46.84%
BioAffinity Technologies shares are trading higher...
Unlock content with
Pro Subscription
3 weeks ago
-44.5%
BioAffinity Technologies shares are trading lower after the company announced the pricing of its $3.25 million offering.
2 months ago · businesswire.com
Case Study: bioAffinity Technologies' Positive CyPath® Lung Result Leads to Detecting Breast Cancer RecurrenceSAN ANTONIO--(BUSINESS WIRE)-- #BIAF--In another case study, CyPath® Lung helped physicians identify and treat a recurrence of breast cancer in a high-risk patient.